Clinical Trials Browser

Phase 2 × Lymphoma, B-Cell × 10-propargyl-10-deazaaminopterin × Clear all

NCT00998946 2021-11-05

Study of Pralatrexate to Treat Participants With Relapsed or Refractory B-cell Non-Hodgkin's Lymphoma

Phase 2 Completed

29 enrolled 8 charts

Recurrence, Lymphoma, B-Cell